Radiotherapy of oligometastatic prostate cancer: a systematic review
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Radiotherapy of oligometastatic prostate cancer: a systematic review
Authors
Keywords
-
Journal
Radiation Oncology
Volume 16, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-03-09
DOI
10.1186/s13014-021-01776-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prostate cancer with low burden skeletal disease at diagnosis: outcome of concomitant radiotherapy on primary tumor and metastases
- (2020) Chiara Lucrezia Deantoni et al. BRITISH JOURNAL OF RADIOLOGY
- Influence of localization of PSMA-positive oligo-metastases on efficacy of metastasis-directed external-beam radiotherapy—a multicenter retrospective study
- (2020) N.-S. Schmidt-Hegemann et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
- (2020) Silke Gillessen et al. EUROPEAN UROLOGY
- Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
- (2020) Matthias Guckenberger et al. LANCET ONCOLOGY
- Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy
- (2020) Ann-Kathrin Oehus et al. BMC CANCER
- Prognostic risk classification for biochemical relapse-free survival in patients with oligorecurrent prostate cancer after [68Ga]PSMA-PET-guided metastasis-directed therapy
- (2020) Marco M. E. Vogel et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Clinical outcome of PSMA-guided radiotherapy for patients with oligorecurrent prostate cancer
- (2020) Stefan A. Koerber et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer
- (2020) Ryan Phillips et al. JAMA Oncology
- METASTASIS-DIRECTED THERAPY (SBRT) GUIDED BY PET-CT 18F-CHOLINE VERSUS PET-CT 68Ga-PSMA IN CASTRATION SENSITIVE OLIGORECURRENT PROSTATE CANCER: A COMPARATIVE ANALYSIS OF EFFECTIVENESS
- (2020) Rosario Mazzola et al. Clinical Genitourinary Cancer
- Patterns of Recurrence and Modes of Progression Following Metastasis Directed Therapy in Oligometastatic Castration Sensitive Prostate Cancer
- (2020) Matthew P. Deek et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Treatment outcomes of metastasis-directed treatment using 68Ga-PSMA-PET/CT for oligometastatic or oligorecurrent prostate cancer: Turkish Society for Radiation Oncology group study (TROD 09-002)
- (2020) Pervin Hurmuz et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Oncological Outcomes of Metastasis-Directed Therapy in Oligorecurrent Prostate Cancer Patients Following Radical Prostatectomy
- (2020) Gaëtan Devos et al. Cancers
- 68Ga-PSMA-PET/CT-based radiosurgery and stereotactic body radiotherapy for oligometastatic prostate cancer
- (2020) Goda Kalinauskaite et al. PLoS One
- Local and metastatic curative radiotherapy in patients with de novo oligometastatic prostate cancer
- (2020) C. Reverberi et al. Scientific Reports
- Oligometastatic prostate cancer: the game is afoot
- (2019) Andrea Lancia et al. CANCER TREATMENT REVIEWS
- Trends in Management of Oligometastatic Hormone-Sensitive Prostate Cancer
- (2019) Gargi Kothari et al. Current Oncology Reports
- 68Ga-PSMA PET/CT-based metastasis-directed radiotherapy for oligometastatic prostate cancer recurrence after radical prostatectomy
- (2019) C. Artigas et al. WORLD JOURNAL OF UROLOGY
- Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study
- (2019) Luca Triggiani et al. WORLD JOURNAL OF UROLOGY
- Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy
- (2019) Elise De Bleser et al. EUROPEAN UROLOGY
- Stereotactic body radiotherapy for bone oligometastatic disease in prostate cancer
- (2019) Priyanka H. Patel et al. WORLD JOURNAL OF UROLOGY
- Prostate-specific membrane antigen-positron emission tomography/computed tomography (PSMA-PET/CT)-guided stereotactic ablative body radiotherapy for oligometastatic prostate cancer: a single-institution experience and review of the published literature
- (2019) Wee Loon Ong et al. BJU INTERNATIONAL
- Radiation Therapy in the Definitive Management of Oligometastatic Prostate Cancer: The Johns Hopkins Experience
- (2019) Matthew P. Deek et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Predictive factors for survival outcomes of oligometastatic prostate cancer patients treated with metastases-directed therapy: a recursive partitioning-based analysis
- (2019) Ciro Franzese et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Recurrence pattern of stereotactic body radiotherapy in oligometastatic prostate cancer: a multi-institutional analysis
- (2019) Luca Nicosia et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Prostate-specific Membrane Antigen Positron Emission Tomography–detected Oligorecurrent Prostate Cancer Treated with Metastases-directed Radiotherapy: Role of Addition and Duration of Androgen Deprivation
- (2019) Stephanie G.C. Kroeze et al. European Urology Focus
- Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial
- (2018) Shankar Siva et al. EUROPEAN UROLOGY
- Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
- (2018) Silke Gillessen et al. EUROPEAN UROLOGY
- Prognostic Value of [ 18 F]-Fluoromethylcholine Positron Emission Tomography/Computed Tomography Before Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer
- (2018) Matthijs Cysouw et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial
- (2018) Christos E. Kyriakopoulos et al. JOURNAL OF CLINICAL ONCOLOGY
- Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial
- (2018) Piet Ost et al. JOURNAL OF CLINICAL ONCOLOGY
- Stereotactic body radiotherapy for castration-sensitive prostate cancer bone oligometastases
- (2018) Giuseppe Fanetti et al. MEDICAL ONCOLOGY
- Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy
- (2018) Nina-Sophie Schmidt-Hegemann et al. Radiation Oncology
- PSMA-PET based radiotherapy: a review of initial experiences, survey on current practice and future perspectives
- (2018) Sebastian Zschaeck et al. Radiation Oncology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Salvage extended field or involved field nodal irradiation in 18F-fluorocholine PET/CT oligorecurrent nodal failures from prostate cancer
- (2018) Alexis Lépinoy et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Patterns of progression after 68Ga-PSMA-ligand PET/CT-guided radiotherapy for recurrent prostate cancer
- (2018) Alexander Soldatov et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Oligometastatic prostate cancer: Reality or figment of imagination?
- (2018) Corey C. Foster et al. CANCER
- Identifying the Optimal Candidate for Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer: Results from a Large, Multi-institutional Analysis
- (2018) Nicola Fossati et al. EUROPEAN UROLOGY
- Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial
- (2018) Christopher C Parker et al. LANCET
- EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer
- (2017) Philip Cornford et al. EUROPEAN UROLOGY
- Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
- (2017) Karim Fizazi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
- (2017) Nicholas D. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Detection level and pattern of positive lesions using PSMA PET/CT for staging prior to radiation therapy
- (2017) Nina-Sophie Schmidt-Hegemann et al. Radiation Oncology
- Oligometastases in prostate cancer
- (2017) René Baumann et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Evolving Treatment of Oligometastatic Hormone-Sensitive Prostate Cancer
- (2017) Jessica M. Clement et al. Journal of Oncology Practice
- Toxicity and efficacy of salvage carbon 11-choline positron emission tomography/computed tomography-guided radiation therapy in patients with lymph node recurrence of prostate cancer
- (2016) Andrei Fodor et al. BJU INTERNATIONAL
- Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional Analysis
- (2016) Piet Ost et al. EUROPEAN UROLOGY
- Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer
- (2016) Jonathan L. Muldermans et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Meta-Analysis Evaluating the Impact of Site of Metastasis on Overall Survival in Men With Castration-Resistant Prostate Cancer
- (2016) Susan Halabi et al. JOURNAL OF CLINICAL ONCOLOGY
- Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
- (2016) Nicholas D James et al. LANCET
- [18F]Choline PET/CT and stereotactic body radiotherapy on treatment decision making of oligometastatic prostate cancer patients: preliminary results
- (2016) Francesco Pasqualetti et al. Radiation Oncology
- 68Ga-PSMA ligand PET/CT-based radiotherapy in locally recurrent and recurrent oligometastatic prostate cancer
- (2016) Christoph Henkenberens et al. STRAHLENTHERAPIE UND ONKOLOGIE
- CyberKnife Stereotactic Ablative Radiotherapy as an Option of Treatment for Patients With Prostate Cancer Having Oligometastatic Lymph Nodes
- (2016) Aleksandra Napieralska et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- Stereotactic body radiotherapy in oligometastatic prostate cancer patients with isolated lymph nodes involvement: a two-institution experience
- (2016) Gianluca Ingrosso et al. WORLD JOURNAL OF UROLOGY
- Salvage Stereotactic Body Radiotherapy for Patients With Prostate Cancer With Isolated Lymph Node Metastasis: A Single-Center Experience
- (2015) Elisabetta Ponti et al. Clinical Genitourinary Cancer
- 68Ga-PSMA PET/CT for restaging recurrent prostate cancer: which factors are associated with PET/CT detection rate?
- (2015) Francesco Ceci et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Evaluation of Hybrid 68Ga-PSMA Ligand PET/CT in 248 Patients with Biochemical Recurrence After Radical Prostatectomy
- (2015) M. Eiber et al. JOURNAL OF NUCLEAR MEDICINE
- Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
- (2015) Christopher J. Sweeney et al. NEW ENGLAND JOURNAL OF MEDICINE
- Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
- (2014) Karel Decaestecker et al. Radiation Oncology
- Stereotactic radiotherapy for isolated nodal recurrence of prostate cancer
- (2014) B. Detti et al. WORLD JOURNAL OF UROLOGY
- Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastases
- (2013) Ulrike Schick et al. ACTA ONCOLOGICA
- Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
- (2013) Ali Afshar-Oromieh et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Salvage Stereotactic Body Radiotherapy for Patients With Limited Prostate Cancer Metastases: Deferring Androgen Deprivation Therapy
- (2012) Patrick Berkovic et al. Clinical Genitourinary Cancer
- Robotic Image-Guided Stereotactic Radiotherapy, for Isolated Recurrent Primary, Lymph Node or Metastatic Prostate Cancer
- (2011) Barbara Alicja Jereczek-Fossa et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now